Furthermore, we identified multiple, additional hallmarks of CACs harboring Mir34a-deficient myeloid cells, such as increased expression of Mmp9 in neutrophils and elevated expression of Zeb2 in an inflammatory subtype of CAC tumor cells. This evidence concerns the gene MMP9 and neoplasm.